Results 1 to 10 of about 949,115 (186)

Bispecific antibodies for viral immunotherapy [PDF]

open access: yesHuman Vaccines & Immunotherapeutics, 2017
Bispecific antibody engineering, in which binding specificities toward 2 distinct epitopes are combined into a single molecule, can greatly enhance immunotherapeutic properties of monoclonal antibodies.
Elisabeth K. Nyakatura   +2 more
doaj   +3 more sources

VIRAL ANTIBODIES IN PRESCHOOL CHILDREN [PDF]

open access: yesIranian Journal of Public Health, 1974
One hundred sera from children 1 - 6 years of age, representative of a large serum collection, were tested for the prevalence of antibodies against different viruses.
S. Saidi
doaj   +2 more sources

When viral infections meet the anti-MDA5 antibody-positive dermatomyositis [PDF]

open access: yesFrontiers in Immunology
Anti-melanoma differentiation-related gene 5 (MDA5) antibody-positive dermatomyositis (anti-MDA5+ DM) is recognized as a distinct subtype of dermatomyositis, characterized by its frequent association with interstitial lung disease (ILD), particularly ...
Shuzi Liu   +5 more
doaj   +2 more sources

A simple and rapid method for generating antibodies against bovine alphaherpesvirus 1 viral proteins through immunization with virus-infected murine cells [PDF]

open access: yesBiochemistry and Biophysics Reports
Bovine alphaherpesvirus 1 (BoAHV-1) infects cattle and typically results in significant economic losses for the cattle industry worldwide. Currently, antibodies targeting only a limited number of viral proteins are commercially available.
Jiayu Lin   +6 more
doaj   +2 more sources

Platelet antibodies in viral hepatitis

open access: yesThe Turkish Journal of Pediatrics, 1987
O Hasdal, S Ozsoylu, N Koçak
doaj   +2 more sources

Blocking entry of hepatitis B and D viruses to hepatocytes as a novel immunotherapy for treating chronic infections [PDF]

open access: yes, 2021
Background. Chronic hepatitis B and D virus (HBV/HDV) infections can cause cancer. Current HBV therapy using nucleoside analogues (NAs) is life-long and reduces but does not eliminate the risk of cancer.
Ahlén, G   +13 more
core   +1 more source

Viral antibodies in multiple sclerosis [PDF]

open access: yesThe Italian Journal of Neurological Sciences, 1982
The sera of 176 MS patients and of 150 healthy adult controls were assayed for antibodies against mumps, rubella, Sendai and herpes simplex viruses, a higher prevalence of measles c.f.a. having already been demonstrated in the MS patients. The CSF of 48 of the MS patients were subjected to the same tests.
Ferrante, P.   +3 more
openaire   +2 more sources

Viral antibodies in infectious mononucleosis [PDF]

open access: yesFEMS Immunology & Medical Microbiology, 1994
Patients with Epstein-Barr virus (EBV) infectious mononucleosis (IM) usually develop heterophilic antibodies and some autoantibodies. Antibodies to rubella, measles, adeno-, entero-, herpes simplex, cytomegalo- and varicella-zoster viruses were titrated in sera from IM patients and matched healthy controls using the complement fixation test (CFT) and ...
G, Haukenes   +5 more
openaire   +3 more sources

Viral Antibodies in Diabetes Mellitus [PDF]

open access: yesBMJ, 1969
Sera from 123 patients with diabetes mellitus of recent onset, 155 patients with diabetes of more than two years' duration, and 250 normal persons were collected over a period of two and a half years. All sera were tested for neutralizing antibody to Coxsackie virus types B1-6, and a sample was tested for complement-fixing antibody to a number of viral,
D R, Gamble   +4 more
openaire   +2 more sources

Unbiased interrogation of memory B cells from convalescent COVID-19 patients reveals a broad antiviral humoral response targeting SARS-CoV-2 antigens beyond the spike protein

open access: yesVaccine: X, 2021
Patients who recover from SARS-CoV-2 infections produce antibodies and antigen-specific T cells against multiple viral proteins. Here, an unbiased interrogation of the anti-viral memory B cell repertoire of convalescent patients has been performed by ...
Jillian M. DiMuzio   +14 more
doaj   +1 more source

Home - About - Disclaimer - Privacy